Saheli Sadanand: It was Great Chatting with Vivek Subbiah in Nashville
Saheli Sadanand, Deputy Editor of Nature Medicine, shared a post on LinkedIn by Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, adding:
“It was great chatting with Vivek Subbiah, MD, in Nashville earlier this week! I’m proud of all the fantastic work in our oncology Nature Medicine research portfolio and looking forward to continuing to support innovative studies in this area. Stay tuned for more cool papers in the months to come!”
Quoting Vivek Subbiah‘s post:
“Engaging discussion with Saheli Sadanand the amazing Deputy Editor at Nature Medicine
I made the case: This is a terrific time in oncology research. AI is accelerating insights. Precision medicine is personalizing care. Drug development is defying limits. We have challenges in real world implementation.
Journals like Nature, Nature Medicine, Nature Magazine must keep leading and prioritizing oncology, amplifying breakthroughs, and shaping the future of care.
Thanks Saheli for listening to my pitch and sharing the vision for Oncology.”
More posts featuring Saheli Sadanand and Vivek Subbiah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023